Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Alzheimer’s Breakthrough Targets Genes That May Raise Risk up to 12 Times

Could an effective gene therapy for Alzheimer's be on the horizon? Dr. Kevin Kemp told Newsweek that he thinks so.

A groundbreaking gene therapy developed by scientists at the University of Bristol aims to target the APOE4 gene, a high-risk genetic factor for Alzheimer's disease. The therapy converts APOE4 into the lower-risk APOE3 gene, potentially reducing the risk of Alzheimer's by up to 12 times. The research, led by Dr. Kevin Kemp, began in 2024 and has shown promising results in converting APOE4 to APOE3 in human immune cells without causing harm to surrounding cells' DNA.

The team is optimistic that this gene editing technique could eventually help in preventing or slowing down Alzheimer's in those at the highest risk. However, the therapy is still in the experimental stage, and several challenges, including ensuring the safety and efficiency of the gene-editing machinery in the human brain, must be overcome before it can become a viable treatment.

Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at newsweek.com →

More in Health & Medicine

More from Friday 20 November →